AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
JPMorgan: Chinese Tech Stocks Remain Attractive Amid Turmoil
ByAinvest
Friday, May 30, 2025 8:07 am ET1min read
JPMorgan Asset Management's Aisa Ogoshi believes Chinese tech stocks remain attractive despite market turmoil, calling them "alive and well." Ogoshi notes that the sector has faced challenges, but remains a key part of the Chinese economy and offers long-term growth potential. Despite the volatility, Ogoshi sees the sector as a good investment opportunity for the future.
Chinese tech stocks, despite facing challenges and market volatility, continue to be seen as attractive investment opportunities by industry experts. Aisa Ogoshi, APAC Equities Portfolio Manager at JPMorgan Asset Management, recently stated that Chinese tech stocks are "alive and well" and remain a key part of the Chinese economy, offering long-term growth potential [2].Ogoshi's optimism is supported by the sector's resilience in the face of various challenges. For instance, the dwindling stockpile of Nvidia processors and tightening U.S. export controls have prompted major Chinese tech companies like Alibaba, Tencent, and Baidu to explore homegrown chips to meet domestic AI demand [1]. This shift underscores the sector's adaptability and innovation.
Moreover, the sector's long-term prospects are bolstered by significant advancements in biotechnology and drug development. Innovent Biologics, Inc., for example, has published groundbreaking clinical study results of mazdutide, a dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, in The New England Journal of Medicine (NEJM). This study, the first of its kind to be published in NEJM, highlights China's growing capabilities in drug development and biotechnology innovation [3].
In conclusion, while market turmoil may present short-term challenges, the long-term prospects for Chinese tech stocks remain promising. The sector's adaptability, innovation, and strategic importance to the Chinese economy make it an attractive investment opportunity for the future.
References:
[1] https://www.marketscreener.com/quote/stock/NVIDIA-CORPORATION-57355629/news/Chinese-tech-companies-prepare-for-AI-future-without-Nvidia-FT-reports-50107473/
[2] https://www.marketscreener.com/news/latest/China-Tech-Alive-And-Well-JPMorgan-50114267/
[3] https://www.marketscreener.com/quote/stock/INNOVENT-BIOLOGICS-INC-49476402/news/Innovent-Biologics-Inc-Announces-Phase-3-Clinical-Study-of-Mazdutide-in-Chinese-Adults-with-Overwe-50065095/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet